Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Alcohol Drinking 11Pancreatic Neoplasms 6Neoplasms 5Smoking Cessation 4Pancreatic Cyst 4Cancer Pain 4Agnosia 4Smoking 3Pain 3Depression 3Prostatic Neoplasms 2Postoperative Complications 2Neoplasms, Cystic, Mucinous, and Serous 2Multiple Endocrine Neoplasia Type 1 2Lymphoma, Follicular 2Lymphoma 2Leukemia 2Infections 2Gliosarcoma 2Glioblastoma 2Condylomata Acuminata 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Cardiovascular Diseases 2Breast Neoplasms 2Brain Neoplasms 2Alcoholism 2Wounds and Injuries 1Warts 1Waldenstrom Macroglobulinemia 1

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 35Peripheral Blood Stem Cell Transplantation 31dinutuximab 29Radiotherapy 29Granulocyte Colony-Stimulating Factor 29sargramostim 283-Iodobenzylguanidine 27Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16Ifosfamide 15naxitamab 14fludarabine phosphate 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuroblastoma × Ethanol × Clear all
NCT00471679 2013-03-05

Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
12 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡